Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival

Antimicrobial Agents and Chemotherapy
Jeannine M RefosWendy W J van de Sande

Abstract

Host chitinases, chitotriosidase and acidic mammalian chitinase (AMCase), improved the antifungal activity of caspofungin (CAS) against Aspergillus fumigatus in vitro These chitinases are not constitutively expressed in the lung. Here, we investigated whether chitosan derivatives were able to induce chitinase activity in the lungs of neutropenic rats and, if so, whether these chitinases were able to prolong survival of rats with invasive pulmonary aspergillosis (IPA) or of rats with IPA and treated with CAS. An oligosaccharide-lactate chitosan (OLC) derivative was instilled in the left lung of neutropenic rats to induce chitotriosidase and AMCase activities. Rats instilled with OLC or with phosphate-buffered saline (PBS) were subsequently infected with A. fumigatus and then treated with suboptimal doses of CAS. Survival, histopathology, and galactomannan indexes were determined. Instillation of OLC resulted in chitotriosidase and AMCase activities. However, instillation of OLC did not prolong rat survival when rats were subsequently challenged with A. fumigatus In 5 of 7 rats instilled with OLC, the fungal foci in the lungs were smaller than those in rats instilled with PBS. Instillation of OLC did not significantly enhance the...Continue Reading

References

Nov 3, 1995·The Journal of Biological Chemistry·R G BootJ M Aerts
Nov 22, 2000·The Journal of Biological Chemistry·R G BootJ M Aerts
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
May 17, 2005·The Journal of Gene Medicine·Magnus Köping-HöggårdPer Artursson
Oct 11, 2005·International Immunology·Marco van EijkJohannes M F G Aerts
May 22, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Jian YangShi-Qian Chen
May 26, 2007·QJM : Monthly Journal of the Association of Physicians·O S Zmeili, A O Soubani
Jan 16, 2008·Antimicrobial Agents and Chemotherapy·Wendy W J van de SandeIrma A J M Bakker-Woudenberg
Jan 27, 2009·Cellular and Molecular Life Sciences : CMLS·C Gordon-ThomsonG P M Moore
Feb 27, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kohta MohriHirokazu Okamoto
Aug 28, 2010·Biomaterials·Christian GorzelannyStefan W Schneider
Oct 8, 2011·International Journal of Pharmaceutics·Z MohammadiM Rafiee Tehrani
Feb 17, 2015·Journal of Biomedical Materials Research. Part a·Steinunn GudmundsdottirPetur H Petersen
Oct 22, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul E VerweijJacques F Meis
Feb 9, 2016·Nature Reviews. Microbiology·Lars P Erwig, Neil A R Gow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.